ER Stress-Response Signaling Regulates Chamber-Specific Growth between Right and Left Ventricles during Postnatal
Insights
The IRE1α-Xbp1-Vimp/Rpn2 pathway controls heart ventricle size by regulating cardiomyocyte growth and death. This pathway is crucial for normal heart development and may offer therapeutic targets for heart diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Developmental Biology
Background:
- Differential growth between the left ventricle (LV) and right ventricle (RV) is essential for normal heart development, resulting in a larger LV in adults.
- Factors regulating this chamber-specific growth remain largely unknown.
Purpose of the Study:
- To investigate the role of the IRE1α-Xbp1 pathway in regulating differential ventricular growth.
- To identify downstream targets of spliced Xbp1 (sXbp1) involved in cardiomyocyte function.
Main Methods:
- Utilized mouse models with genetic or pharmacological manipulation of IRE1α or Xbp1 in cardiomyocytes.
- Employed primary cultured neonatal cardiomyocytes and CRISPR/Cas9/AAV9-based somatic mutagenesis.
- Generated heart-specific mosaic mutant mouse models to study sXbp1 downstream targets.
Main Results:
- Inactivation of IRE1α or Xbp1 led to smaller LV size, reduced cardiomyocyte proliferation, and increased cell death, without affecting the RV.
- Induction of IRE1α or sXbp1 enhanced ventricular size by promoting cardiomyocyte proliferation and growth, and reducing apoptosis.
- Identified Vimp and Rpn2 as direct binding partners of sXbp1, regulating cardiomyocyte proliferation, growth, and death, with observed protein misfolding in mutants.
Conclusions:
- The IRE1α-Xbp1-Vimp/Rpn2 axis orchestrates differential ventricular size during postnatal development by controlling cardiomyocyte proliferation, hypertrophic growth, and death.
- This pathway regulates protein homeostasis, impacting heart development and potentially offering therapeutic avenues for heart conditions.
Background:
Differential growth between the left (LV) and right ventricles (RV) is a cornerstone of normal heart morphogenesis after birth, leading to the relatively larger and dominant LV over RV in the adult heart regarding size and function. Yet, little is known about the factors that regulate this chamber-specific growth.
Methods:
We used both loss-and gain-of-function mouse models, achieved through genetic or pharmacological manipulation of IRE1α or Xbp1 in cardiomyocytes. We also used primary cultured neonatal cardiomyocytes to explore the roles of IRE1α, spliced Xbp1 (sXbp1: activated form), and newly identified sXbp1 downstream targets. In addition, we generated heart-specific mosaic mutant mouse models using CRISPR/Cas9/AAV9-based somatic mutagenesis to elucidate the roles of sXbp1 downstream targets in cardiomyocytes.
Results:
Pharmacological inactivation of IRE1α and genetic depletion of Xbp1 resulted in a smaller LV size, due to decreased cardiomyocyte proliferation and hypertrophic growth, as well as increased cardiomyocyte death. These effects were not observed in the RV. Cardiomyocyte-specific induction of IRE1α or sXbp1 led to increased ventricular size in both ventricles, through enhanced cardiomyocyte proliferation and hypertrophic growth in both LV and RV, and reduced apoptosis in the RV. We identified two ER resident transmembrane proteins, Vimp and Rpn2, as direct binding partners of sXbp1 in targeted gene regulation at the chromatin level. CRISPR/Cas9/AAV9-based somatic mutagenesis mouse models for Vimp and Rpn2 revealed that both genes regulate cardiomyocyte proliferation, hypertrophic growth, and death. We also observed accumulated misfolded proteins in these two mutant hearts. Conclusions We demonstrate that the IRE1α-Xbp1-Vimp/Rpn2 axis regulates differential ventricular size between LV and RV during postnatal development by orchestrating cardiomyocyte proliferation, hypertrophic growth, and death through regulating protein homeostasis.
Clinical Perspective:
What Is New: IRE1α-Xbp1 axis is dominantly activated in the LV cardiomyocyte during the postnatal period in mouse heart.IRE1α-Xbp1 mediated ER stress signaling increases cardiomyocyte proliferation and hypertrophic growth and decreases apoptosis in the postnatal period.Activated Xbp1 directly regulates LV-specific cardiomyocyte protein homeostasis via interaction with ER membrane targeted Vimp and Rpn2.What Are the Clinical Implications?: Differential heart growth patterns between the LV and RV are critical for normal morphogenesis and function of each ventricle.Control of protein homeostasis by modulating ER stress signaling could be a potential therapeutic approach for single-chamber heart diseases.
Related Concept Videos
Chambers of the Heart
Deoxygenated blood from the body is received in the right...
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitral Regurgitation I: Introduction
Regulation of Angiogenesis and Blood Supply


